EIF3E Antikörper (N-Term)
-
- Target Alle EIF3E Antikörper anzeigen
- EIF3E (Eukaryotic Translation Initiation Factor 3 Subunit E (EIF3E))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser EIF3E Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunofluorescence (IF)
- Spezifität
- Reacts with human eIF3e protein
- Aufreinigung
- Purified (protein A)
- Immunogen
- Partial recombinant human eIF3e protein (N terminal part) FLAG-Tagged
- Top Product
- Discover our top product EIF3E Primärantikörper
-
-
- Applikationshinweise
-
Working dilution: Optimal dilutions should be determined by the end user.
The following are guidelines only :
IF(1:100 - 1:1000) WB(1:500 - 1:2000) - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Must be reconstituted in distilled water.
- Buffer
- Tris 0,1M, glycine 0,1M, sucrose 2 %
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
- Haltbarkeit
- 24 months
-
- Target
- EIF3E (Eukaryotic Translation Initiation Factor 3 Subunit E (EIF3E))
- Andere Bezeichnung
- Eukaryotic Translation Initiation Factor 3 Subunit E (EIF3E Produkte)
- Hintergrund
- Belongs to the eIF-3 subunit E family. Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis.
- UniProt
- P60228
- Pathways
- Ribonucleoprotein Complex Subunit Organization, Hepatitis C
-